AHA: Risk for Ischemic CV Events Lower With Colchicine After MI
Risk for composite efficacy end point reduced with colchicine versus placebo after myocardial infarction
AHA: Impact of Valsartan Recall Examined for Ontario, Canada
Immediate increase in emergency department visits for hypertension seen after generic valsartan recall
About Half of Middle-Age Adults Believe They May Develop Dementia
Only 5.2 percent of patients had discussed dementia prevention with their physician
AHA: Predictors for Meeting LDL-C, SBP Goals ID’d in ISCHEMIA
Older age, male sex, high-intensity statin use, lower baseline LDL-C predict LDL-C goal attainment
FDA Sends Warning Letter About OTC Drugs to Dollar Tree
Letter outlines corrective actions company needs to take, including ensuring they do not import impure drugs
FDA Panel: Expand Use of Fish Oil Drug Vascepa
Research shows drug can reduce rates of dangerous cardiovascular events in high-risk patients
CDC: Number of Vaping-Linked Lung Illnesses Up to 2,172
Meanwhile, Apple has removed 181 vaping-related apps from its mobile App Store worldwide
American College of Allergy, Asthma & Immunology, Nov. 7-11
The 2019 Annual Meeting of the American College of Allergy, Asthma & Immunology The annual meeting of the American College of Allergy, Asthma...
Too Few Medicare Beneficiaries With Diabetes Getting Eye Exams
Variation in prevalence of eye exams from 43.9 percent in Puerto Rico to 64.8 percent in Rhode Island
Risk for Disability Worsening Increased for MS With Comorbid Depression
Risk increased for persons with depression defined by ICD-10, those exposed to antidepressants
